Better Choice Company announced it has signed a research and development partnership with Aimia Pet Health to develop a GLP1 supplement for overweight pets under its Halo brand. More than half of all dogs and cats worldwide are classified as overweight or obese and can suffer from the same weight-related health complications as humans - including arthritis, diabetes, and high blood pressure. Following the successful creation by Pfizer of its Slentrol medication, Better Choice will work with Aimia Pet Health to developed treats and toppers to safely combat pet obesity.

The goal of the research and development work is to mirror the weight loss benefits of leading brands for domestic animals and in humans including Slentrol, Wegovy, Ozempic, and Monjaro with added protein and nutrients from halo products to promote lean muscle and overall pet health.